| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is actively advancing in the field of obesity treatment through multiple pipeline projects and recent FDA approval for innovative products like Ebglyss. The company's significant investment in drug development underscores its commitment to bringing successful weight loss treatments to market, enhancing overall sales and brand reputation. With a strong portfolio of successful products, Eli Lilly is well-positioned to address growing health demands, particularly in the obesity sector. However, navigating the competitive pharmaceutical landscape remains a challenge. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.6 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.8, and the negative at -0.2 on 2024-10-03. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (4.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-03 | 0%(0%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| 2024-09-18 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2024-07-24 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2024-06-26 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2024-04-08 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2024-03-28 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2024-03-14 | 0%(0%) | 0 | 0% | 0.3 | 3 | -1 | |||||||
| 2024-03-02 | 0%(0%) | 0 | 0% | 0.4 | 3.1 | -1 | |||||||
| 2023-12-07 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | -1 | |||||||
| 2023-12-06 | 0%(0%) | 0 | 0% | 0.5 | 4.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:25:12 Eli Lilly's drugs being adopted by the NHS for weight-loss treatment showcases regulatory support and broadens access for patients, underscoring the positive impact on public health. |
| 2025-05-19 17:25:12 With shortages resolved, Eli Lilly is expected to see a shift in market dynamics which may facilitate increased sales and competition among pharmaceutical companies. |
| 2025-05-19 17:25:12 Eli Lilly's impressive performance against competition and overall gains in the market are key indicators of strong company earnings and financial health. |
| 2025-05-19 17:25:12 The resolution of shortages for Eli Lilly's weight-loss and diabetes medications indicates improvements in supply chain management and market stability. |
| 2025-05-19 17:25:12 Eli Lilly's significant financial commitment of $4.5 billion to enhance its manufacturing capabilities reflects a positive outlook on its growth and innovation potential. |